GSTM1 and thalassemia: We found that 3,542 of the former 3,706 (95.6%) fetuses were at risk of having the three targeted severe thalassemia diseases, i.e., homozygous α0-thalassemia (Hb Bart’s hydrops fetalis), β-thalassemia major and Hb E-β0-thalassemia.